{
    "2019-12-10": [
        [
            {
                "time": "",
                "original_text": "智飞生物实控人再转公司股份，旗下子公司屡获资金投入",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "实控人",
                        "子公司",
                        "资金投入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物实控人作价近7亿元转让公司1.05%股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "实控人",
                        "股份转让",
                        "7亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "疫苗龙头被减持！啥情况？实控人：减持为减压！不炒房，不炒股 减持股份",
                "features": {
                    "keywords": [
                        "疫苗",
                        "龙头",
                        "减持",
                        "实控人",
                        "减压"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "10月公司新闻聚焦：珠海国资17亿揽入宝鹰股份 东旭光电今日复牌",
                "features": {
                    "keywords": [
                        "珠海国资",
                        "宝鹰股份",
                        "东旭光电",
                        "复牌"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "建筑装饰",
                        "光电科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "近7亿元引入战略投资者，智飞生物实控人转让1.05%股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "实控人",
                        "战略投资者",
                        "股份转让"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物实控人减持1680万股为‘减压’ 减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "实控人",
                        "减持",
                        "1680万股",
                        "减压"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}